Discussion
People in remission from immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have a higher risk of certain major cardiovascular events, particularly stroke, according to a…
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsPeople in remission from immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have a higher risk of certain major cardiovascular events, particularly stroke, according to a…
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsFour weekly injections of the antibody therapy daratumumab restored a key enzyme’s activity and triggered a two-year recovery for a woman with hard-to-treat immune-mediated…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.